Content feed Comments Feed

Mimi Breastfriend's FORUM

This site contains specific questions and answers about cancer - especially breast cancer - being collected from various sources over the internet. The only reason for serving this site is solely to provide references to similar questions often asked by the patients, survivors, families of patients to the experts, or even to a fellow sufferer alone who might not be able to give satisfactorily answers. There are at least 40 cases of breast cancers are reviewed here (in Bahasa Indonesia) and get very clear answers from the experts ...

Mimi Breastfriend On The News

On the 3rd week of December 2008 I received 3 short messages from a new friend on facebook called Mr. Zulham Mubarak, a writer for the Daily Jawapost. Conclusion of the three messages were clear; he requested for a casual meeting to talk more about my breast cancer and works on this blog which he intended to cover as an exclusive report for the Jawapost newspaper. Unfortunately, the day he scheduled to meet me was the very same day of my undergoing a routine schedule for therapy. Naturally, with deep regret I had to tell him how sorry I was for being unable to fulfill the request. But a couple weeks later .....

Mimi Breastfriend's Animated Video Collection

I bet many of us - including myself - still don't understand well how exactly cancer cells develop in the human body and cost so much damages to our vital organs and other human supporting life. In my long-and-tiring efforts so far trying to learn about it, I found some video clips which could at least help to answer the question. Among those videos which I think rather easier to understand are some cuts of video animation about cancer that I've collected here for the good sake of knowledge. For those who want to know more about breast cancer, please visit ....

Mimi Breastfriends in English

This site was initially created in Bahasa Indonesia, the language widely spoken among friends and readers within the country whom I would like very much to share everything I've learned about breast cancer to. However, shortly after I published it in mid July 2007 I received number of suggestions from some English speaking readers who had encouraged me to have it in English as well. Therefore, although I understand there are actually tons of "advanced" information about cancer and of course, breast cancer available in English on the net and naturally, will make this one nearly nothing but eventually I decided to take those suggestions into an act. So ...

Breast Cancer Risk Calculator

Do you worry about breast cancer? Estimate your chance of having breast cancer based on personal risk factors. This practice is worth for your early awareness and necessary prevention. Check your possible risk simply by answering these questions ...
CahayaBiru.com

Drug Eruptions

Posted by Mimi Friday, July 1, 2011

Any drug can cause a skin reaction, but some classes of drugs are characteristically associated with certain types of reaction.

Not all dermatological problems produce visible signs. The skin may appear normal with marked pruritus. It may be difficult to decide if the drug is really the cause of the problem and to withdraw it, especially if it is providing important treatment. Early withdrawal of the offending drug may limit its adverse effects.

Many of these reactions are immunological in origin. Possibly the drug acts as a hapten and binds to proteins to form a structure that the immune system recognises as "not self".
Most immunologically mediated reactions can be allocated to one of the Gel and Coombs' classes of hypersensitivity:

  • Type I is mediated by IgE and results in urticaria, angioedema, and anaphylaxis. They are often caused by proteins and especially insulin.
  • Type II is a cytotoxic reaction which produces haemolysis and purpura. They are caused by penicillin, cephalosporins, sulphonamides, and rifampin.
  • Type III is immune complex reactions, which result in vasculitis, serum sickness, and urticaria. They can be caused by salicylates, chlorpromazine and sulphonamides.
  • Type IV is delayed-type reactions with cell-mediated hypersensitivity, which result in contact dermatitis, exanthematous reactions, and photoallergic reactions. These reactions are the most common and are usually caused by topical applications. Antibodies can be demonstrated in fewer than 5% of drug reactions, as the problem is cell-mediated. Type IV reactions are not dose-dependent. They usually begin one to three weeks after medication is started. This is significantly slower than most other reactions. There may be eosinophilia, and they may recur if other drugs that are chemically related are used.
Epidemiology

Adverse drug reactions occur in about 2-5% of patients in hospital and follow about 1% of prescriptions in the community. They are more common in women than men and more common in the elderly but the elderly also take more drugs.

Most are mild reactions and simply an inconvenience, although they may be very uncomfortable. About 1 in 1,000 in the hospital setting are rather more severe.

Notification of adverse drug reaction is on a voluntary basis through the Yellow Card scheme in the British National Formulary.

Diagnosis
  • History and examination are as important here as in any field.1
  • Most drugs will cause a reaction fairly soon after they have started, although type IV reactions take longer than others. When a patient develops a dermatological problem it is often difficult to decide which, if any, drugs are responsible.2
  • Take a careful history, avoiding being too ready to accept the patient's diagnosis of what is to blame, especially if they are on multiple medication. Take note of all medication including prescribed, over-the-counter (OTC), "alternative" and illicit drugs. It is not only prescription only medications (POMs) that can cause trouble and patients may be surprised to learn that OTCs, "natural therapies" and illegal drugs can also have adverse effects.
  • Urticaria may not be due to a drug at all but the ingestion of strawberries or shellfish. There may be a viral infection. Has the patient had that drug before? Were there any problems then?
Associated drugs and rashes

Acneform lesions

These are different from acne vulgaris in that they tend to be over the upper body rather than the face and there are no comedomes.
Typical drugs are corticosteroids, halogens, haloperidol, hormones, isoniazid, lithium, phenytoin, and trazodone:

  • The halogens are usually bromide or iodide.
  • The hormones may be anabolic steroids taken illicitly by body builders or some athletes. Progestogens can also be a problem. This tends to be in low oestrogen, high progestogen oral contraceptive pills rather than progestogen-only pills or depot and implant contraceptives.

Acute generalised exanthematous pustulosis

  • This is often abbreviated to AGEP. It produces an acute onset of fever and generalised scarlatiniform erythema with many small, sterile, nonfollicular pustules. It appears like pustular psoriasis.
  • Most cases are caused by antibiotics, often in the first few days of administration.
  • Some may be viral infections, mercury exposure, or UV radiation. They resolve spontaneously and rapidly, with fever and pustules lasting 7-10 days before desquamation over a few days.
  • Typical drugs include beta-lactam antibiotics, macrolides, and less commonly, a wide variety of drugs including paracetamol, carbamazepine, tetracyclines, diltiazem, furosemide, hydrochlorothiazide, hydroxychloroquine, nifedipine, phenytoin, pseudoephedrine, ranitidine, sertraline, simvastatin, terbinafine and vancomycin.

Alopecia

It may occur with ACE inhibitors, allopurinol, anticoagulants, azathioprine, bromocriptine, beta blockers, cyclophosphamide, hormones - especially those with androgenic effects, indinavir, non-steroidal anti-inflammatory drugs (NSAIDs), phenytoin, methotrexate, retinoids, and valproate. It is usual with cylcophosphamide therapy but is quite rare with the other medications.

Bullous pemphigoid

Lesions like bullous pemphigoid may occur with penicillamine, captopril, chloroquine, ciprofloxacin, enalapril, furosemide, neuroleptics, penicillins, PUVA, sulfasalazine, and terbinafine

Erythema nodosum

See separate article Erythema Nodosum. Lesions most often occur with oral contraceptives but can occur with halogens, penicillin, sulphonamides, and tetracyclines.

Erythroderma

This is a diffuse redness of the skin. Offending drugs include allopurinol, anticonvulsants, captopril, chloroquine, chlorpromazine, cimetidine, diltiazem, lithium, nitrofurantoin, omeprazole, phenytoin, St John's wort and sulphonamides.

Fixed drug eruptions

  • These are when lesions recur in the same area when the same drug is given.
  • Plaques are circular, violaceous and oedematous and they resolve with macular hyperpigmentation. The latent period is half an hour to eight hours after taking the drug. Perioral and periorbital lesions may occur, but the hands, feet, and genitalia are the usual sites to be involved.
  • Fixed drug eruptions are well-recognised with many drugs including anticonvulsants, aspirin and NSAIDs, benzodiazepines, cetirizine, ciprofloxacin, clarithromycin, doxycycline, fluconazole, hydroxyzine, lamotrigine, loratadine, metronidazole, oral contraceptives, penicillins, phenytoin, sulphonamides, tetracyclines and zolmitriptan.
DRUG RASH (OM15a.jpg)

Fig. 1. A generalised fixed drug eruption.
DRUG RASH - CLOSE UP VIEW (OM15b.jpg)

Fig. 2. The same - closer.

Hypersensitivity syndromes

True allergy may occur with allopurinol, amitriptyline, carbamazepine, lamotrigine, minocycline, NSAIDs, olanzapine, phenytoin, spironolactone, and zidovudine.

Lichenoid reactions

Lesions are similar in appearance to lichen planus and there may be marked pruritus.
They can accompany amlodipine, antimalarials, beta blockers, captopril, diflunisal (now withdrawn), diltiazem, enalapril, furosemide, glimepiride, gold, leflunomide, penicillamine, phenothiazine, proton pump inhibitors, sildenafil, tetracycline, thiazides, and ursodeoxycholic acid.

Lupus drug reactions

Unlike other drug reactions, lupus tends to require a long period of exposure.3 It produces symptoms like systemic lupus erythematosus
(SLE) but with skin findings being uncommon, or drug-induced subacute cutaneous lupus erythematosus (SCLE), which is characterised by annular psoriasiform, nonscarring lesions in a typical pattern for photosensitivity.
For SLE effects, hydralazine and minocycline are best known. For SCLE, hydrochlorothiazide is the most common.

Photosensitivity

The most common offenders are ACE inhibitors, amiodarone, amlodipine, celecoxib, chlorpromazine and other phenothiazines, diltiazem, furosemide, lovastatin, nifedipine, quinolones, sulphonamides, tetracyclines, and thiazides.

Urticaria

The most likely drugs are bupropion, carbamazepine, chlordiazepoxide, fluoxetine, imipramine, lamotrigine, lithium, paroxetine, and trazodone.

Vasculitis

This is most likely with fluoxetine, paroxetine, and trazodone.

There are many other well-known reactions that are associated with drugs used in cancer chemotherapy and cytokine therapy. A list of such problems plus a more comprehensive list of other drug reaction may be found in the emedicine link at the end.

Potentially fatal drug eruptions

Most drug eruptions are unpleasant rather than potentially life-threatening. There are two that are worthy of special mention.

Stevens-Johnson syndrome

See related separate article Stevens-Johnson syndrome. This is a much more serious drug eruption.4 It may be the result of malignancy in adults or viral infection in children but drugs should be considered as the potential culprit. It may be associated with allopurinol, anticonvulsants, aspirin and NSAIDS, carbamazepine, cimetidine, ciprofloxacin, codeine, diltiazem, erythromycin, furosemide, griseofulvin, indinavir, nitrogen mustard, penicillin, phenothiazines, phenytoin, ramipril, rifampicin, sulphonamides including co-trimoxazole, and tetracyclines. Of these, sulphonamides are most often implicated.

Toxic epidermal necrolysis

See separate article Toxic Epidermal Necrolysis. Responsible agents include allopurinol, anticonvulsants, aspirin and NSAIDs, isoniazid, penicillins, phenytoin, prazosin, sulphonamides including co-trimoxazole, tetracyclines and vancomycin. Both Stevens-Johnson syndrome and toxic epidermal necrolysis are often caused by infections, especially herpes simplex virus but, when caused by drugs, it is usually penicillins or sulphonamides.5

Clinical features are similar in all causes:

  • The reaction often starts with fever, sore throat, chills, headache, arthralgia, vomiting and diarrhoea and malaise.
  • Lesions may occur anywhere, but most commonly affect the palms, soles, dorsum of hands and extensor surfaces. The rash may be confined to any one area of the body, most often the trunk. There is no pruritus.
  • Mouth involvement may be severe enough that patients may not be able to eat or drink.
  • Genitourinary involvement result in dysuria or an inability to pass urine
  • The rash can begin as macules that develop into papules, vesicles, bullae, urticarial plaques, or confluent erythema.
  • The typical lesion has the appearance of a target, which is considered pathognomonic.
  • As stated above, toxic epidermal necrolysis is similar but more severe. Mucocutaneous detachment is more marked and a greater area is usually involved.
  • Both conditions require admission to hospital if not already there. The skin loss of toxic epidermal necrolysis is best managed in a burns unit.
  • Both, but especially toxic epidermal necrolysis may result in scarring, blindness and even death.
Investigations
  • Usually no specific investigation is undertaken other than removing the suspected drug or even several drugs and monitoring for improvement.
  • FBC may show leukopenia, thrombocytopenia, and eosinophilia in patients with serious drug eruptions.
  • In the severe forms of reactions, LFTs and renal function should be monitored. In vasculitis, CXR and urinalysis are required.
  • In lupus-type responses, autoantibodies may be positive. Antihistone antibodies are often found in drug-induced SLE, whilst anti-Ro/SS-A antibodies are typical of drug-induced SCLE.
  • Prick testing can be dangerous and patch testing is often of little value. it must be interpreted with caution.6
  • Oral provocation tests may be regarded as the "gold standard" but they have to be conducted under strict supervision.
  • In chronic cases, biopsy may be helpful.
Associated diseases

Although compromise of the immune system dampens the immune response it may increase the risk of adverse reactions, and patients with HIV have 10 times the average risk of drug reactions. The risk of serious adverse reactions such as Stevens-Johnson syndrome is even higher.

Common causes of nonimmunological reactions

Not all drug reactions are immunological in origin.

  • The Jarisch-Herxheimer reaction classically occurs on starting penicillin for syphilis. It is due to the rapid destruction of spirochetes and the release of endotoxins from these organisms. It may occur with rickettsial illness such as Lyme disease as the organisms are similar. It may occur if penicillin is given for another condition and it was not known that the patient had syphilis. If the reaction is to be anticipated, the diagnosis of syphilis having been made, it is usual to start steroids at a dose such as prednisolone 20 mg a day, a day before the first injection of penicillin and to tail off quite rapidly over the next few days. It is important to make the diagnosis and not to mistake it for allergy to penicillin and stop the antibiotic or syphilis will remain inadequately treated. This reaction may sometimes be seen with griseofulvin or ketoconazole given for dermatophyte infections, and diethylcarbamazine treatment of onchocerciasis.
  • Photosensitivity is not an immunological reaction. It may be caused by production of free radicals or reactive oxygen species. There is an excessive sensitivity to sunburn. The phenothiazines and doxycycline are often involved.
  • Antimetabolites almost invariably cause certain adverse effects such as hair loss with cyclophosphamide.
  • Argyria is the accumulation of silver from silver nitrate nasal sprays. It causes blue-grey discoloration of skin and nails.
  • Aspirin and other NSAIDs can act on mast cells directly and cause release of histamine and other mediators without any immunological reaction. Other drugs that may do do include X-ray contrast media, cimetidine, quinine, hydralazine, atropine, vancomycin, tubocurarine, opiates, cytokines and even alcohol.
  • Idiosyncratic reactions are unpredictable. In slow acetylators, drugs such as isoniazid may accumulate and cause peripheral neuropathy. If a patient with infectious mononucleosis is given ampicillin or amoxycillin there will almost invariably be a rash and the patient will probably be incorrectly labelled as allergic to penicillin. Penicillin V is the drug of choice for streptococcal sore throat and amoxycillin must not be given for throat infections, especially in young people.
Management

In uncomplicated cases, remove the offending drug and, if the condition resolves as expected, make notes to the effect that the patient has an adverse reaction to that drug. It may not be possible to be conclusive about which drug, if any was responsible and, whilst caution is prudent, it is inappropriate to be too eager to label patients as allergic to any specific drug. Many people have probably been wrongly labelled as allergic to penicillin over the years and denied this very safe and effective treatment but failure to note allergy can even be fatal.

Provided that they are not thought to be part of the problem, antihistamines may give some symptomatic relief.

Prognosis

Most cases resolve without complications but it may take 10 to 14 days for the rash to disappear. Patients with exanthematous eruptions will have mild desquamation as the rash resolves.

The Stevens Johnson syndrome has a mortality of around 5% whilst toxic epidermal necrolysis carries a mortality of 20-30%

Summary

This is a vast but very important area:

  • Drug reactions are iatrogenic and hence contravene the principle of primum non nocere - 'first do no harm'.
  • Patients are often too eager to attribute adverse reactions to prescribed medication but they may be correct. The doctor must keep an open and self-critical mind.
  • History and examination are very important and ask about OTC, "alternative" and illicit medication.
  • Most drug reactions are minor and self-limiting but certain red flags must be noted:
    • If the patient is systemically unwell this is serious.
    • If the rash is extensive, it could progress to a serious exfoliative dermatitis.
    • Detachment of the skin is serious.
    • Involvement of mucous membranes including eyes and genitalia may suggest Stevens-Johnson syndrome.
  • The doctor must appreciate the protean nature of many adverse reactions and have a low threshold for stopping the drug, although if it is an essential drug this will require more circumspection.
  • Accurate record-keeping is important to prevent a patient from being given a drug after an adverse reaction to it. On the other hand it is important not to be too eager to label a patient as allergic on tenuous and unsatisfactory grounds. It is a matter of looking at the evidence and balancing the risks.

Document references
  1. Daoud MS, Schanbacher CF, Dicken CH; Recognizing cutaneous drug eruptions. Reaction patterns provide clues to causes.; Postgrad Med. 1998 Jul;104(1):101-4, 107-8, 114-5. [abstract]
  2. Nigen S, Knowles SR, Shear NH; Drug eruptions: approaching the diagnosis of drug-induced skin diseases.; J Drugs Dermatol. 2003 Jun;2(3):278-99. [abstract]
  3. Rubin RL; Drug-induced lupus.; Toxicology. 2005 Apr 15;209(2):135-47. [abstract]
  4. Hazin R, Ibrahimi OA, Hazin MI, et al; Stevens-Johnson syndrome: pathogenesis, diagnosis, and management. Ann Med. 2008;40(2):129-38. [abstract]
  5. Forman R, Koren G, Shear NH; Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.; Drug Saf. 2002;25(13):965-72. [abstract]
  6. Barbaud A; Drug patch testing in systemic cutaneous drug allergy.; Toxicology. 2005 Apr 15;209(2):209-16. [abstract]

Internet and further reading
  • Blume JE; Drug eruptions; emedicine January 2009
  • Vervleot D, Durham S; Adverse drug reactions. Clinical review; BMJ 1998;316:1511-1514 ( 16 May ) Good pictures too.
Acknowledgements EMIS is grateful to Dr Hayley Willacy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2011.
Document ID: 1117
Document Version: 27
Document Reference: bgp2356
Last Updated: 14 Dec 2009
Planned Review: 13 Dec 2012

What is Health Informatics?

Posted by Mimi Monday, October 18, 2010

Health informatics (also called health care informatics, healthcare informatics, medical informatics or biomedical informatics) is a discipline at the intersection of information science, computer science, and health care. It deals with the resources, devices, and methods required to optimize the acquisition, storage, retrieval, and use of information in health and biomedicine. Health informatics tools include not only computers but also clinical guidelines, formal medical terminologies, and information and communication systems. It is applied to the areas of nursing, clinical care, dentistry, pharmacy, public health and (bio)medical research.

Aspects of the field

  • Architectures for electronic medical records and other health information systems used for billing, scheduling, and research
  • Decision support systems in healthcare, including clinical decision support systems and information workflows
  • Standards (e.g. DICOM, HL7) and integration profiles (e.g. Integrating the Healthcare Enterprise) to facilitate the exchange of information between healthcare information systems - these specifically define the means to exchange data, not the content
  • Controlled medical vocabularies (CMVs) such as the Systematized Nomenclature of Medicine, Clinical Terms (SNOMED CT), MEDCIN, Logical Observation Identifiers Names and Codes (LOINC), OpenGALEN Common Reference Model or the highly complex UMLS - used to allow a standard, accurate exchange of data content between systems and providers
  • Use of hand-held or portable devices to assist providers with data entry/retrieval or medical decision-making, sometimes called mHealth.
  • The international standards on the subject are covered by ICS 35.240.80[1] in which ISO 27799:2008 is one of the core components.[2]
  • Molecular bioinformatics and clinical informatics have converged into the field of translational bioinformatics.

History
Medical informatics began to take off in the US in the 1950s with the rise of computers.

Early names for medical informatics included medical computing, medical computer science, computer medicine, medical electronic data processing, medical automatic data processing, medical information processing, medical information science, medical software engineering, and medical computer technology.

Since the 1970s the coordinating body has been the International Medical Informatics Association (IMIA).

Medical informatics in the United States
The earliest use of computation for medicine was for dental projects in the 1950s at the United States National Bureau of Standards by Robert Ledley.[3]

The next step in the mid 1950s were the development of expert systems such as MYCIN and INTERNIST-I. In 1965, the National Library of Medicine started to use MEDLINE and MEDLARS. At this time, Neil Pappalardo, Curtis Marble, and Robert Greenes developed MUMPS (Massachusetts General Hospital Utility Multi-Programming System) in Octo Barnett's Laboratory of Computer Science [4] at Massachusetts General Hospital in Boston.[5] In the 1970s and 1980s it was the most commonly used programming language for clinical applications. The MUMPS operating system was used to support MUMPS language specifications. As of 2004[update], a descendent of this system is being used in the United States Veterans Affairs hospital system. The VA has the largest enterprise-wide health information system that includes an electronic medical record, known as the Veterans Health Information Systems and Technology Architecture (VistA). A graphical user interface known as the Computerized Patient Record System (CPRS) allows health care providers to review and update a patient’s electronic medical record at any of the VA's over 1,000 health care facilities.

In the 1970s a growing number of commercial vendors began to market practice management and electronic medical records systems. Although many products exist, only a small number of health practitioners use fully featured electronic health care records systems.

Homer R. Warner, one of the fathers of medical informatics,[6] founded the Department of Medical Informatics at the University of Utah in 1968, and the American Medical Informatics Association (AMIA) has an award named after him on application of informatics to medicine.

Current state of health informatics and policy initiatives
This article reads like a review and may need a cleanup. Please help improve this article to make it neutral in tone and meet Wikipedia's quality standards. (August 2009)

Americas
Argentina
Since 1997, the Buenos Aires Biomedical Informatics Group, a nonprofit group, represents the interests of a broad range of clinical and non-clinical professionals working within the Health Informatics sphere. Its purposes are:

  • Promote the implementation of the computer tool in the healthcare activity, scientific research, health administration and in all areas related to health sciences and biomedical research.
  • Support, promote and disseminate content related activities with the management of health information and tools they used to do under the name of Biomedical informatics.
  • Promote cooperation and exchange of actions generated in the field of biomedical informatics, both in the public and private, national and international level.
  • Interact with all scientists, recognized academic stimulating the creation of new instances that have the same goal and be inspired by the same purpose.
  • To promote, organize, sponsor and participate in events and activities for training in computer and information and disseminating developments in this area that might be useful for team members and health related activities.

The Argentinian health system is very heterogeneous, because of that the informatics developments shows an heterogeneous stage. Lot of private Health Care center has develop system, as the German Hospital of Buenos Aires who was one of the first in develop the electronic health records system.

Brazil Main article: Brazilian Society of Health Informatics
The first applications of computers to medicine and healthcare in Brazil started around 1968, with the installation of the first mainframes in public university hospitals, and the use of programmable calculators in scientific research applications. Minicomputers, such as the IBM 1130 were installed in several universities, and the first applications were developed for them, such as the hospital census in the School of Medicine of Ribeirão Preto and patient master files, in the Hospital das Clínicas da Universidade de São Paulo, respectively at the cities of Ribeirão Preto and São Paulo campi of the University of São Paulo. In the 1970s, several Digital Corporation and Hewlett Packard minicomputers were acquired for public and Armed Forces hospitals, and more intensively used for intensive-care unit, cardiology diagnostics, patient monitoring amd other applications. In the early 1980s, with the arrival of cheaper microcomputers, a great upsurge of computer applications in health ensued, and in 1986 the Brazilian Society of Health Informatics was founded, the first Brazilian Congress of Health Informatics was held, and the first Brazilian Journal of Health Informatics was published.

Canada
Health Informatics projects in Canada are implemented provincially, with different provinces creating different systems. A national, federally-funded, not-for-profit organization called Canada Health Infoway was created in 2001 to foster the development and adoption of electronic health records across Canada. As of December 31, 2008 there were 276 EHR projects under way in Canadian hospitals, other health-care facilities, pharmacies and laboratories, with an investment value of $1.5-billion from Canada Health Infoway.[7]

Provincial and territorial programmes include the following:

  • eHealth Ontario was created as an Ontario provincial government agency in September 2008. It has been plagued by delays and its CEO was fired over a multimillion-dollar contracts scandal in 2009.[8]
  • Alberta Netcare was created in 2003 by the Government of Alberta. Today the netCARE portal is used daily by thousands of clinicians. It provides access to demographic data, prescribed/dispensed drugs, known allergies/intolerances, immunizations, laboratory test results, diagnostic imaging reports, the diabetes registry and other medical reports. netCARE interface capabilities are being included in electronic medical record products which are being funded by the provincial government.

United States
In 2004 the U.S. Department of Health and Human Services (HHS) formed the Office of the National Coordinator for Health Information Technology (ONCHIT). The mission of this office is widespread adoption of interoperable electronic health records (EHRs) in the US within 10 years. See quality improvement organizations for more information on federal initiatives in this area.

The Certification Commission for Healthcare Information Technology (CCHIT), a private nonprofit group, was funded in 2005 by the U.S. Department of Health and Human Services to develop a set of standards for electronic health records (EHR) and supporting networks, and certify vendors who meet them. In July, 2006 CCHIT released its first list of 22 certified ambulatory EHR products, in two different announcements.[9]

Europe For more details on this topic, see European Federation for Medical Informatics.
The European Union's Member States are committed to sharing their best practices and experiences to create a European eHealth Area, thereby improving access to and quality health care at the same time as stimulating growth in a promising new industrial sector. The European eHealth Action Plan plays a fundamental role in the European Union's strategy. Work on this initiative involves a collaborative approach among several parts of the Commission services.[10][11] The European Institute for Health Records is involved in the promotion of high quality electronic health record systems in the European Union.[12]

The NHS in England has contracted out to several vendors for a National Medical Informatics system 'NPFIT' that divides the country into five regions and is to be united by a central electronic medical record system nicknamed "the spine".[13] The project, in 2010, is seriously behind schedule and its scope and design are being revised in real time. The degree of computerisation in NHS secondary was quite high before NPfIT and that programme has had the unfortunate effect of largely stalling further development of the installed base.

Almost all general practices in England and Wales are computerised and patients have relatively extensive computerised primary care clinical records. Computerisation is the responsibility of individual practices and there is no single, standardised GP system. Interoperation between primary and secondary care systems is rather primitive.

Scotland has an approach to central connection under way which is more advanced than the English one in some ways. Scotland has the GPASS system whose source code is owned by the State, and controlled and developed by NHS Scotland. It has been provided free to all GPs in Scotland but has developed poorly.[citation needed] Discussion of open sourcing it as a remedy is occurring.

The European Commission's preference, as exemplified in the 5th Framework[14] as well as currently pursued pilot projects,[15] is for Free/Libre and Open Source Software (FLOSS) for healthcare.
[edit] Asia and Oceania

In Asia and Australia-New Zealand, the regional group called the Asia Pacific Association for Medical Informatics (APAMI)[16] was established in 1994 and now consists of more than 15 member regions in the Asia Pacific Region.

Australia
The Australasian College of Health Informatics (ACHI) is the professional association for health informatics in the Asia-Pacific region. It represents the interests of a broad range of clinical and non-clinical professionals working within the health informatics sphere through a commitment to quality, standards and ethical practice.[17] Founded in 2002, ACHI is increasingly valued[18] for its thought leadership, its trusted advisors and national and international experts in Health Informatics. ACHI is an academic institutional member of the International Medical Informatics Association (IMIA)[19] and a full member of the Australian Council of Professions.[20] ACHI is a sponsor of the "e-Journal for Health Informatics",[21] an indexed and peer-reviewed professional journal. ACHI has also supported the "Australian Health Informatics Education Council" (AHIEC) since its founding in 2009.[22]

Although there are a number of health informatics organisations in Australia, the Health Informatics Society of Australia[23] (HISA) is regarded as the major umbrella group and is a member of the International Medical Informatics Association (IMIA). Nursing informaticians were the driving force behind the formation of HISA, which is now a company limited by guarantee of the members. The membership comes from across the informatics spectrum that is from students to corporate affiliates. HISA has a number of branches (Queensland, New South Wales, Victoria and Western Australia) as well as special interest groups such as nursing (NIA), pathology, aged and community care, industry and medical imaging (Conrick, 2006).

China Main article: Health informatics in China

Hong Kong
In Hong Kong a computerized patient record system called the Clinical Management System (CMS) has been developed by the Hospital Authority since 1994. This system has been deployed at all the sites of the Authority (40 hospitals and 120 clinics), and is used by all 30,000 clinical staff on a daily basis, with a daily transaction of up to 2 millions. The comprehensive records of 7 million patients are available on-line in the Electronic Patient Record (ePR), with data integrated from all sites. Since 2004 radiology image viewing has been added to the ePR, with radiography images from any HA site being available as part of the ePR.

The Hong Kong Hospital Authority placed particular attention to the governance of clinical systems development, with input from hundreds of clinicians being incorporated through a structured process. The Health Informatics Section in Hong Kong Hospital Authority[24] has close relationship with Information Technology Department and clinicians to develop healthcare systems for the organization to support the service to all public hospitals and clinics in the region.

The Hong Kong Society of Medical Informatics (HKSMI) was established in 1987 to promote the use of information technology in healthcare. The eHealth Consortium has been formed to bring together clinicians from both the private and public sectors, medical informatics professionals and the IT industry to further promote IT in healthcare in Hong Kong.[25]

India Main article: Indian Association for Medical Informatics

New Zealand
Health Informatics is taught at four New Zealand universities. The most mature and established is the Otago programme which has been offered for over a decade.[26]

Saudi Arabia
The Saudi Association for Health Information (SAHI) was established in 2006[27] to work under direct supervision of King Saud University for Health Sciences to practice public activities, develop theoretical and applicable knowledge, and provide scientific and applicable studies.[28]

Health informatics law. For more details on this topic, see Health law.

Health informatics law deals with evolving and sometimes complex legal principles as they apply to information technology in health-related fields. It addresses the privacy, ethical and operational issues that invariably arise when electronic tools, information and media are used in health care delivery. Health Informatics Law also applies to all matters that involve information technology, health care and the interaction of information. It deals with the circumstances under which data and records are shared with other fields or areas that support and enhance patient care.

Clinical Informatics
Clinical Informatics is concerned with use information in health care by clinicians.[29][30]

Clinical informaticians transform health care by analyzing, designing, implementing, and evaluating information and communication systems that enhance individual and population health outcomes, improve [patient] care, and strengthen the clinician-patient relationship. Clinical informaticians use their knowledge of patient care combined with their understanding of informatics concepts, methods, and health informatics tools to:

  • Assess information and knowledge needs of health care professionals and patients,
  • Characterize, evaluate, and refine clinical processes,
  • Develop, implement, and refine clinical decision support systems, and
  • Llead or participate in the procurement, customization, development, implementation, management, evaluation, and continuous improvement of clinical information systems.

Physicians who are board-certified in clinical informatics collaborate with other health care and information technology professionals to develop health informatics tools which promote patient care that is safe, efficient, effective, timely, patient-centered, and equitable.

Translational bioinformatics
With the completion of the human genome and the recent advent of high throughput sequencing and genome-wise association studies of single nucleotide polymorphisms, the fields of molecular bioinformatics, biostatistiques, statistical genetics and clinical informatics are converging into the emerging field of translational bioinformatics.[31][32][33]

Leading health informatics and medical informatics journals Main article: List of medical and health informatics journals

See also
Related concepts


Standards/frameworks and governance

Technologies
  • eMix
References
  1. "35.240.80: IT applications in health care technology". ISO. ans this file Retrieved 2008-06-15.
  2. Fraser, Ross. "ISO 27799: Security management in health using ISO/IEC 17799". (See this file) . Retrieved 2008-06-15.
  3. Sittig DF, Ash JS, Ledley RS (2006). "The story behind the development of the first whole-body computerized tomography scanner as told by Robert S. Ledley". Journal of the American Medical Informatics Association 13 (5): 465–9. doi:10.1197/jamia.M2127. PMID 16799115.
  4. MGH - Laboratory of Computer Science
  5. Edwin D. Reilly (2003). Milestones in Computer Science and Information Technology. Greenwood Press. pp. 161. ISBN 978-1573565219.
  6. Patton GA, Gardner RM (1999). "Medical informatics education: the University of Utah experience". Journal of the American Medical Informatics Association 6 (6): 457–65. PMID 10579604.
  7. See this file
  8. "Head of eHealth Ontario is fired amid contracts scandal, gets big package". CBC News. 2009-06-07. (See this file) . Retrieved 2009-08-26.
  9. Certification Commission for Healthcare Information Technology (July 18, 2006): CCHIT Announces First Certified Electronic Health Record Products. Retrieved July 26, 2006.
  10. European eHealth Action Plan
  11. European eHealth Action Plan i2010
  12. "Electronic Health Records for Europe". European Space Agency. 2005. (See this file) Retrieved 2009-01-13.
  13. National Programme for IT in the NHS
  14. Cordis FP5web
  15. European Patient Smart Open Services
  16. "Asia Pacific Association of Medical Informatics". (See this file)
  17. "Australasian College of Health Informatics" (See this file) Retrieved 3 May 2010. Australasian College of Health Informatics
  18. University of Sydney Current Developments in Health Informatics
  19. "International Medical Informatics Association - Academic Institutional Members - Australia - Australian College of Health Informatics". 12 August 2009. (See this file) h Retrieved 22 February 2010.
  20. ACHI Memberships ACHI memberships: Professions Australia
  21. eJHI - electronic Journal of Health Informatics (open access journal)
  22. Australian Health Informatics Education Council (AHIEC) AHIEC Auspicing Organisations
  23. "Health Informatics Society of Australia Ltd" (See this file) Retrieved 3 April 2010.
  24. Health Informatics Section in Hong Kong Hospital Authority
  25. eHealth Consortium
  26. Karolyn Kerr; Rowena Cullen, Jan Duke, Alec Holt, Ray Kirk, Peter Komisarczuk, Jim Warren and Shona Wilson (2006). "Health Informatics Capability Development In New Zealand - A Report to the Tertiary Education Commission". (see this file) Retrieved 2009-01-08.
  27. "Medical Pharmaceutical Information Association (MedPharmInfo)". Imia.org. 2008-05-18. see this file. Retrieved 2010-07-29.
  28. [1][dead link]
  29. Gardner RM, Overhage JM, Steen EB, et al. (2009). "Core content for the subspecialty of clinical informatics". Journal of the American Medical Informatics Association 16 (2): 153–7. doi:10.1197/jamia.M3045. PMID 19074296.
  30. Safran C, Shabot MM, Munger BS, et al. (2009). "Program requirements for fellowship education in the subspecialty of clinical informatics". Journal of the American Medical Informatics Association 16 (2): 158–66. doi:10.1197/jamia.M3046. PMID 19074295.
  31. Butte, AJ (2009). "Translational bioinformatics applications in genome medicine.". Genome medicine 1 (6): 64. doi:10.1186/gm64. PMID 19566916.
  32. Kann, M. G. (2009). "Advances in translational bioinformatics: computational approaches for the hunting of disease genes". Briefings in Bioinformatics 11 (1): 96. doi:10.1093/bib/bbp048. PMID 20007728.
  33. Lussier, YA; Butte, AJ; Hunter, L (2010). "Current methodologies for translational bioinformatics" Journal of biomedical informatics 43 (3): 355–7. doi: 10.1016/j.jbi.2010.05.002. PMID 20470899.

External links


Thank You

Posted by Mimi Sunday, March 21, 2010


My truly grateful to all dear friends who have sent me beautiful greetings and wishes 
on my birthday ~ March 21, 2010.
You are indeed wonderful 
I love you.

With love,
Mimi   

Ask The Experts

Posted by Mimi Monday, March 15, 2010

Home Page last modified on: January 4, 2010

Breastcancer.org’s Ask-the-Expert Online Conferences offer site visitors the opportunity to voice their questions to health professionals. Leading breast cancer experts provide answers and insights on screening, treatment, side effect management, nutrition, relationships, employment issues, and more. Browse the transcripts archives to read what their experts have to say!


TRANSCRIPT ARCHIVES

Breast Cancer Risk Factors
March 2008: Breast Cancer Risk and Your Family
February 2006: Risk Reduction
August 2005: Environmental Issues and Breast Cancer

Screening and Testing

July 2003: Breast Cancer Screening

Your Pathology Report

November 2004: Your Operative and Pathology Reports

Types of Breast Cancer

July 2008: Triple-Negative Breast Cancer
October 2006: Inflammatory Breast Cancer
November 2005: Hormone-Receptor-Negative Breast Cancer

Treatment Issues

October 2008: Managing Chemo Brain
May 2008: After Surgery: Short-term and Long-term Effects
April 2008: Preventing and Treating Arm Lymphedema
January 2008: Managing Fatigue During and After Treatment
May 2007: Reconstruction Updates
September 2006: Open for Your Questions
August 2006: Thinking and Memory Challenges
July 2006: Targeted Therapies: What is Right for You?
April 2006: Young Women and Breast Cancer
April 2005: Reconstruction and Safe, Sexy Cosmetics
April 2004: Hormonal Therapy Updates
March 2004: Radiation Therapy Updates
February 2004: Chemotherapy Updates
November 2003: Breast Reconstruction
February 2003: The Doctor-Patient Relationship
January 2003: Managing Treatment Side Effects
July 2002: Arm Lymphedema Prevention and Management
November 2001: Lesbians and Breast Cancer Treatment
August 2001: No Hair, New Hair, Skin Care
March 2001: Ease Fatigue, Boost Energy

Complementary and Holistic Treatments

March 2007: Complementary Medicine Techniques
September 2005: Traditional Chinese Medicine
March 2005: Acupuncture and Touch Therapies
October 2004: Complementary and Holistic Treatments
October 2002: Complementary and Holistic Treatments

Diet and Nutrition

October 2009: Nutrition Through the Holidays
July 2007: Vitamins and Herbal Supplements
April 2007: Weight Management During and After Breast Cancer
November 2006: Eating and Drinking Through the Holidays
July 2005: Buying Healthy Food and Drink
January 2005: Nutrition and Weight
July 2000: Food for Cancer Recovery

Dealing with Breast Cancer Fears

April 2009: Managing Fear and Anxiety
June 2002: Dealing with Breast Cancer Fears
June 2001: Tackling Fear
June 2000: Easing Breast Cancer Fear

Managing Menopausal Symptoms

August 2008: Managing Menopausal Symptoms
July 2004: Managing Menopausal Symptoms
August 2002: Keeping Your Bones Strong
March 2002: Managing Menopausal Symptoms

Pain

January 2004: Pain Management—Getting the Relief YOU Need
April 2002: Breast Cancer Pain

Day-to-Day Matters

September 2008: Fertility and Pregnancy
September 2007: Working During Treatment
August 2007: Managing Ongoing Medications
January 2007: Sleep Well: Healthy Habits for Good Rest
January 2006: Physical Activity and Breast Cancer
June 1, 2005: Summertime Issues: Treatment and Personal Care
August 2004: Pregnancy and Fertility Issues
May 2003: Taking Care of Yourself
March 2003: Overcoming Depression
October 2001: Quality of Life
September 2001: Stress and Your Immune System
October 2000: Feelings About Breast Cancer

Intimacy and Sexuality

February 2008: Sex, Intimacy, and Breast Cancer
May 2004: Sleep or Sex? You Can Have Both!
February 2002: Intimacy, Sex and Your Love Life
February 2001: Intimacy and Sexuality

Family, Friends, Relationships

February 2007: Partners, Loved Ones, Caregivers: Taking Care of You
May 2006: Talking with Kids About Breast Cancer
March 2006: Coping with Your Changing Feelings and Relationships
September 2004: Family and Loved Ones
August 2000: Kids and Mom's Breast Cancer

Research Advances

December 2009: Updates from the 2009 San Antonio Breast Cancer Symposium
June 2009: Updates from the 2009 ASCO Annual Meeting
December 2008: Updates from the 2008 San Antonio Breast Cancer Symposium
June 2008: Updates from the 2008 ASCO Annual Meeting
December 2007: Updates from the 2007 San Antonio Breast Cancer Symposium
June 2007: Updates from the 2007 ASCO Annual Meeting
December 2006: Updates from the 2006 San Antonio Breast Cancer Symposium
June 2006: Updates from the 2006 ASCO Annual Meeting
December 2005: Updates from the 2005 San Antonio Breast Cancer Symposium
June 15, 2005: Updates from the 2005 ASCO Annual Meeting

Metastatic Breast Cancer

October 2007: Living with Metastatic Breast Cancer
September 2003: Metastatic Breast Cancer

Provided by BREASTCANCER.ORG

Study shows popular antidepressant may cause relapse - or even death.

The popular antidepressant drug Paxil may interfere with breast cancer treatments, making patients more likely to relapse and die, researchers in Canada reported on Monday.

Women who took GlaxoSmithKline's Paxil while taking tamoxifen at the same time were more likely to die of their breast cancer, the researchers found. The longer the overlap between Paxil and tamoxifen, the more likely the patients were to die, they reported in the British Medical Journal.

It is likely because Paxil, sold generically as paroxetine, interferes with the compound the body uses to process tamoxifen, the researchers said.


The information on this site is not intended as a substitute for medical professional's help or advice but is to be used as an aid in understanding today's knowledge about cancer, especially breast cancer. However, a Physician should always be consulted for any health problem or any medical condition you may have experienced concerning breast cancer.

This site provides links to other sites of individual and organization which are considered relevant to the purpose of this health informatics publication as a service to readers. But it is useful to understand that the author is not responsible for any content or information being published by those related sites. Please be well informed. Thank you.





This site worth only:
Want to know how much is yours? Click the image!
Widget by ReviewOfWeb

FEATURED Articles

Search for MORE With GOOGLE

Loading...
Loading...

Followers

Do You Believe That You Are Free From Breast Cancer's Threat?

Do You Think This Site Is Worth Visiting?

More messages are welcome to Mimi's Guestbook or else, please feel free to Contact Me.